Resource Center

Go back to Resource Center

Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics

2004

Journal Article

Authors:
Csaky, K.; Group, C.P.D.T.1Study Rese

Location:
Ft. Lauderdale, FL

Go back to Resource Center